Table 2.
Baseline demographic and clinical characteristics
| Characteristic | Total patients enrolled in the study N = 154 | Patients who received a PRBC transfusion N = 147 |
|---|---|---|
| Sex, n (%) | ||
| Female | 107 (69.5) | 100 (68.0) |
| Male | 47 (30.5) | 47 (32.0) |
| Age, mean (SD), years | 65.3 (9.8) | 65.3 (9.9) |
| < 65 years, n (%) | 70 (45.5) | 66 (44.9) |
| ≥ 65 years, n (%) | 84 (54.5) | 81 (55.1) |
| Primary tumor type, n (%) | ||
| Gynecological cancer | 43 (27.9) | 38 (25.9) |
| Non-small cell lung cancer | 32 (20.8) | 32 (21.8) |
| Small cell lung cancer | 25 (16.2) | 24 (16.3) |
| Gastrointestinal cancer | 19 (12.3) | 18 (12.2) |
| Breast cancer | 14 (9.1) | 14 (9.5) |
| Urogenital cancer | 7 (4.5) | 7 (4.8) |
| Hematological malignancies | 7 (4.5) | 7 (4.8) |
| Othera | 7 (4.5) | 7 (4.8) |
| Chemotherapy type, n (%) | ||
| Platinum | 113 (73.4) | 107 (72.8) |
| Non-platinum | 41 (26.6) | 40 (27.2) |
| Chemotherapy line, n (%) | ||
| First | 100 (64.9) | 95 (64.6) |
| Second | 54 (35.1) | 52 (35.4) |
| Signs and symptoms of anemia, n (%) | ||
| Yes | 137 (89.0) | 133 (90.5) |
| No | 17 (11.0) | 14 (9.5) |
| Comorbidities relevant to the anemia, n (%) | ||
| Yes | – | 41 (27.9) |
| Chronic pulmonary disease | – | 22 (15.0) |
| Congestive heart failure or coronary heart disease | – | 9 (6.1) |
| Cerebral vascular disease | – | 2 (1.4) |
| Otherb | – | 17 (11.6) |
| No | – | 106 (72.1) |
PRBC packed red blood cell, SD standard deviation
aIncludes bone/sarcoma, brain, head and neck, skin, thyroid cancers, or missing
bNot specified